Published in Emerg Infect Dis on April 01, 2012
Refining the plasmid-encoded type IV secretion system substrate repertoire of Coxiella burnetii. J Bacteriol (2013) 0.97
Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. J Clin Microbiol (2014) 0.97
Localizing chronic Q fever: a challenging query. BMC Infect Dis (2013) 0.95
From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clin Microbiol Rev (2017) 0.93
Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther (2013) 0.87
Screening of post-mortem tissue donors for Coxiella burnetii infection after large outbreaks of Q fever in The Netherlands. BMC Infect Dis (2014) 0.81
Targeted screening as a tool for the early detection of chronic Q fever patients after a large outbreak. Eur J Clin Microbiol Infect Dis (2012) 0.80
Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands. PLoS One (2014) 0.80
Coxiella burnetii seroprevalence in small ruminants in The Gambia. PLoS One (2014) 0.80
A fatal case of disseminated chronic Q fever: a case report and brief review of the literature. Infection (2016) 0.79
Persistent high IgG phase I antibody levels against Coxiella burnetii among veterinarians compared to patients previously diagnosed with acute Q fever after three years of follow-up. PLoS One (2015) 0.78
Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever. Clin Vaccine Immunol (2014) 0.78
Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands(1). Emerg Infect Dis (2015) 0.78
Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection. Eur J Clin Microbiol Infect Dis (2014) 0.77
Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever. Front Microbiol (2015) 0.77
Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic. PLoS One (2015) 0.76
Molecular Identification of Q Fever in Patients with a Suspected Diagnosis of Dengue in Brazil in 2013-2014. Am J Trop Med Hyg (2016) 0.75
Coverage of the 2011 Q fever vaccination campaign in the Netherlands, using retrospective population-based prevalence estimation of cardiovascular risk-conditions for chronic Q fever. PLoS One (2015) 0.75
Persistent high antibody titres against Coxiella burnetii after acute Q fever not explained by continued exposure to the source of infection: a case-control study. BMC Infect Dis (2014) 0.75
Chronic Q Fever in Alberta: A Case of Coxiella burnetii Mycotic Aneurysm and Concomitant Vertebral Osteomyelitis. Can J Infect Dis Med Microbiol (2016) 0.75
Population Screening for Chronic Q-Fever Seven Years after a Major Outbreak. PLoS One (2015) 0.75
Modelling the risk of transfusion transmission from travelling donors. BMC Infect Dis (2016) 0.75
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis (2000) 15.05
Q fever. Clin Microbiol Rev (1999) 11.32
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation (2006) 5.97
Natural history and pathophysiology of Q fever. Lancet Infect Dis (2005) 5.48
Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) (2000) 3.95
Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis (2010) 3.84
Q Fever. Vet Microbiol (2009) 3.49
Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol (1994) 3.26
Q fever. Lancet (2006) 2.70
Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med (1993) 2.57
The aging of the immune system. Transpl Int (2009) 2.32
Risks factors and prevention of Q fever endocarditis. Clin Infect Dis (2001) 2.17
Coxiella burnetii blood cultures from acute and chronic Q-fever patients. J Clin Microbiol (1995) 2.01
Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol (2004) 1.74
From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis (2007) 1.73
Chronic Q fever: different serological results in three countries--results of a follow-up study 6 years after a point source outbreak. Clin Infect Dis (2011) 1.68
Q fever in France, 1985-2009. Emerg Infect Dis (2011) 1.62
Q fever. Infect Dis Clin North Am (2008) 1.59
Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands. Transfusion (2011) 1.50
Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis (2007) 1.48
Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis (2011) 1.34
Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis (2006) 1.33
Cardio-Kidney-Damage: a unifying concept. Kidney Int (2010) 1.27
Single-nucleotide-polymorphism genotyping of Coxiella burnetii during a Q fever outbreak in The Netherlands. Appl Environ Microbiol (2011) 1.21
Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int (2011) 1.21
Simplified serological diagnosis of endocarditis due to Coxiella burnetii and Bartonella. Clin Diagn Lab Immunol (2003) 1.10
Q fever in the Netherlands from 2007 to 2010. Neth J Med (2010) 1.05
[Laboratory diagnosis of acute Q fever]. Ned Tijdschr Geneeskd (2010) 1.02
Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis (2006) 1.00
Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol (2011) 0.97
One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection (2010) 0.96
Prevention of Q fever endocarditis. Lancet Infect Dis (2011) 0.95
Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health (2010) 0.88
Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med (2015) 6.25
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med (2005) 4.83
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis (2010) 4.41
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis (2013) 4.08
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med (2008) 3.71
Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data metaanalysis. Am J Obstet Gynecol (2013) 3.10
Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis (2005) 2.64
Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol (2009) 2.35
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J (2012) 2.12
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol (2011) 2.10
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus. Gastroenterology (2010) 1.98
Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol (2011) 1.94
Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care (2010) 1.86
Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis (2010) 1.85
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis (2004) 1.84
Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care (2002) 1.83
Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr (2012) 1.79
Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. PLoS One (2010) 1.72
Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ (2011) 1.70
Interlaboratory evaluation of different extraction and real-time PCR methods for detection of Coxiella burnetii DNA in serum. J Clin Microbiol (2010) 1.65
17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol (2011) 1.65
International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol (2007) 1.58
Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect (2012) 1.50
Genotypic diversity of Coxiella burnetii in the 2007-2010 Q fever outbreak episodes in The Netherlands. J Clin Microbiol (2011) 1.49
Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antivir Ther (2011) 1.48
Management of bacterial urinary tract infections in adult patients with diabetes mellitus. Drugs (2002) 1.48
Adherence in antiretroviral therapy: a review of qualitative studies. AIDS (2007) 1.48
Predominant association of Raoultella bacteremia with diseases of the biliary tract. Scand J Infect Dis (2013) 1.40
Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis (2011) 1.34
The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One (2012) 1.24
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ (2006) 1.22
Single-nucleotide-polymorphism genotyping of Coxiella burnetii during a Q fever outbreak in The Netherlands. Appl Environ Microbiol (2011) 1.21
Performance of the original EuroSCORE. Eur J Cardiothorac Surg (2012) 1.20
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol (2009) 1.19
Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability. Intensive Care Med (2003) 1.18
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. AIDS (2012) 1.17
Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem (2004) 1.16
Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality. AIDS Res Treat (2010) 1.16
Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med (2016) 1.15
Growth and multiplexed analysis of microorganisms on a subdivided, highly porous, inorganic chip manufactured from anopore. Appl Environ Microbiol (2005) 1.13
Human African trypanosomiasis: a review of non-endemic cases in the past 20 years. Int J Infect Dis (2011) 1.12
The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood (2002) 1.12
Antibiotic prophylaxis for high-risk patients with acute Q Fever: no definitive answers yet. Clin Infect Dis (2013) 1.11
Falsification end points for observational studies. JAMA (2013) 1.10
Long-term survival in community-acquired pneumonia caused by other bacteria than pneumococci is impaired more than in pneumococcal pneumonia: effect of underlying disease? Clin Infect Dis (2013) 1.08
Re: Is the Risk Difference Really a More Heterogeneous Measure? Epidemiology (2016) 1.08
Predicting community-acquired pneumonia etiology. Chest (2013) 1.07
Rapid antibiotic sensitivity testing and trimethoprim-mediated filamentation of clinical isolates of the Enterobacteriaceae assayed on a novel porous culture support. J Med Microbiol (2006) 1.04
Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa. PLoS One (2013) 1.03
O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J Immunol (2004) 1.03
Large-scale identification of disease genes involved in acute myeloid leukemia. J Virol (2004) 1.02
Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol (2008) 1.01
Epidemic Q fever in humans in the Netherlands. Adv Exp Med Biol (2012) 1.01
Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One (2013) 1.00
Measuring balance and model selection in propensity score methods. Pharmacoepidemiol Drug Saf (2011) 0.99
Markers of infection in inpatients and outpatients with acute Q-fever. Clin Chem Lab Med (2009) 0.99
A Bayesian decision-support system for diagnosing ventilator-associated pneumonia. Intensive Care Med (2007) 0.99
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. J Acquir Immune Defic Syndr (2013) 0.98
Asymptomatic bacteriuria in women with diabetes mellitus: effect on renal function after 6 years of follow-up. Arch Intern Med (2006) 0.97
Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clin Vaccine Immunol (2011) 0.97
Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. J Clin Microbiol (2014) 0.97
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res (2011) 0.97
Prevention of Q fever endocarditis. Lancet Infect Dis (2011) 0.95
Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study. Pharmacoepidemiol Drug Saf (2014) 0.95
The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. BMC Immunol (2014) 0.95
Predictive value of lymphocytopenia and the neutrophil-lymphocyte count ratio for severe imported malaria. Malar J (2013) 0.94
Potential misinterpretation of treatment effects due to use of odds ratios and logistic regression in randomized controlled trials. PLoS One (2011) 0.93
Strategies for early detection of chronic Q-fever: a systematic review. Eur J Clin Invest (2013) 0.92
The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium. FEMS Yeast Res (2006) 0.92
Propensity score balance measures in pharmacoepidemiology: a simulation study. Pharmacoepidemiol Drug Saf (2014) 0.91
Intrathecal production and secretion of vascular endothelial growth factor during Cryptococcal Meningitis. J Infect Dis (2004) 0.91
Microbiological challenges in the diagnosis of chronic Q fever. Clin Vaccine Immunol (2012) 0.91
Interferon-gamma release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Int J Infect Dis (2008) 0.91
β-Blocker use for patients with or at risk for coronary artery disease. JAMA (2013) 0.91
Adherence to HAART: processes explaining adherence behavior in acceptors and non-acceptors. AIDS Care (2009) 0.91
Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia. Clin Infect Dis (2007) 0.91